3ALOSON A, JOSE M L. Multiple antibiotic resistance in Stenuteophomonas mahophilia [ J ]. Antimicrob Agents Chemother, 1997,41 (5) :1140.
4AVISON M B, HELDREICH C J, HIGGINS G S. ATEM 2 betalactamase encoded on an active Tn1-lick transposon in the genome of a clinical isolate of stenoteophomonas maltophilia [ J ]. Antimicrob Chemother,2000,46 ( 6 ) :879.
7LI X Z,ZHANG L,MECAY G A,et al. Role of the acetyhransferase AAC (6)-Iz modifying enzyme in aminoglycoside resistance in stenoteophomonas mahophilia [ J ]. J Antimicrob Chemother, 2003, 51:803 -811.
10CHANG L L,CHEN H F,CHANG C Y,et al. Contribution of integrona, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenoteophomonas maltophilia [ J ]. J Antimicrob Chemother, 2004,53:553 - 557.
81，National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial disk suceptibility testings[M].NCCLS,1999,19(1):58.
92，Jarlier V,Nicolas MH,Fournier G et al.Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae:hospital prevalence and susceptibility patterns[J].Rev Infect Dis,1988,10:867-878.
103，Philippon A,Arlet G,Lagrange PH.Origin and impact of plasmid-mediated extended-spectrum β-lactamases[J].Eur J Clin Microbiol Infect Dis,1994,13:17-29.
